The effectiveness of 12 core biopsy protocol according to prostate-specific antigen (PSA) level and prostate volume

Korean Journal of Urology

Volumn 47, Issue 11, 2006, Pages 1166-1171

  Kim, Tae Beom ^b   Lee, Sang Eun ^b   Jeong, Hyeon ^a  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Biopsy; Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BIOPSY TECHNIQUE; CANCER DIAGNOSIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL PARAMETERS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY;

EID: 33846916289     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.11.1166     Document Type: Article

References (21)

1. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-4
2. Naughton CK, Smith DS, Humphrey PA, Catalona WJ, Keetch DW. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy core: a retrospective study. Urology 1998;52:808-13
3. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostse cancer. J Urol 1998;159: 471-5
4. Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995;45:2-12
5. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157:199-202
6. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;166:86-91
7. Babaian RJ, Toi A, Kamoi K, Troncoso P, Sweet J, Evans R, et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000;163:152-7
8. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000; 163:163-6
9. Ravery V, Goldblatt L, Royer B, Blanc E, Toublan M, Bocon-Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 2000;164:393-6
10. Stricker HJ, Ruddock LJ, Wan J, Belville WD. Detection of non-palpable prostate cancer. A mathematical and laboratory model. Br J Urol 1993;71:43-6
11. Seong DH, Cho JS, Hong SJ, Chung BH, Choi YD, Kim SJ, et al. The influence of age and prostate volume on the cancer detection rate in Korean men with PSA levels of 4.0 to 10.0 ng/ml: a multicenter, retrospective study. Korean J Urol 2006; 47:353-7
12. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997;50:562-6
13. Lee SB, Kim CS, Ahn HJ. Comparative analysis of sextant and extended prostate biopsy. Korean J Urol 2004;45:524-9
14. Moon KH, Cheon SH, Kim CS. Systematic 10-site prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. Korean J Urol 2000;41:1178-82
15. Presti JC Jr, O'Dowd GJ, Miller MC, Mattu R, Veltri RW. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancerrates: results of a community multipractice study. J Urol 2003;169:125-9
16. Bae KS, Chang SG. Comparative analysis between sextant biopsy and 12-samples needle biopsy for detection of stage T1c prostate cancer. Korean J Urol 2004;45:653-7
17. Durkan GC, Sheikh N, Johnson P, Hildreth AJ, Greene DR. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. BJU Int 2002;89:33-9
18. Park HK, Byun SS, Sohn DW, Hong SK, Lee ES, Lee SE, et al. The efficacy of 12-site biopsy protocol in men with elevated serum prostate-specific antigen level only. Korean J Urol 2005;46:463-6
19. Nanghton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol 2000; 164:388-92
20. Lee SC, Lee SC, Kim WJ. Value of PSA density, PSA velocity and percent free PSA for detection of prostate cancer in patients with serum PSA 4-10ng/ml patients. Korean J Urol 2004;45:747-52
21. Nanghton CK, Ornstein DK, Smith DS, Catalona WJ. Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol 2000; 163:168-71